These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34316957)

  • 1. A Woman With Hypertriglyceridemia Who Acquired Antibody Against GPIHBP1.
    Hirano Y; Suematsu Y; Yano Y; Sato S; Miura SI
    JACC Case Rep; 2020 Jan; 2(1):15-18. PubMed ID: 34316957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylomicronemia from GPIHBP1 autoantibodies.
    Miyashita K; Lutz J; Hudgins LC; Toib D; Ashraf AP; Song W; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
    J Lipid Res; 2020 Nov; 61(11):1365-1376. PubMed ID: 32948662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
    Strøm TB; Tveita AA; Bogsrud MP; Leren TP
    J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes.
    Kurooka N; Eguchi J; Wada J
    J Diabetes Investig; 2023 Oct; 14(10):1148-1156. PubMed ID: 37448184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD.
    Yamamoto H; Onishi M; Miyamoto N; Oki R; Ueda H; Ishigami M; Hiraoka H; Matsuzawa Y; Kihara S
    J Atheroscler Thromb; 2013; 20(10):777-84. PubMed ID: 23831619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men.
    Matsumoto R; Tsunekawa K; Shoho Y; Yanagawa Y; Kotajima N; Matsumoto S; Araki O; Kimura T; Nakajima K; Murakami M
    Lipids Health Dis; 2019 Apr; 18(1):84. PubMed ID: 30947712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis.
    Zhang G; Yang Q; Mao W; Hu Y; Pu N; Deng H; Yu X; Zhang J; Zhou J; Ye B; Li G; Li B; Ke L; Tong Z; Murakami M; Kimura T; Nakajima K; Cao W; Liu Y; Li W
    J Clin Lipidol; 2022; 16(5):626-634. PubMed ID: 36064883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
    N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia.
    Tanaka K; Koseki M; Kato H; Miyashita K; Okada T; Kanno K; Saga A; Chang J; Omatsu T; Inui H; Ohama T; Nishida M; Yamashita S; Sakata Y
    J Atheroscler Thromb; 2023 Jan; 30(1):100-104. PubMed ID: 35185060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis.
    Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P
    J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).
    Reimund M; Larsson M; Kovrov O; Kasvandik S; Olivecrona G; Lookene A
    J Biol Chem; 2015 May; 290(22):13919-34. PubMed ID: 25873395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
    Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined diet and exercise intervention on body weight and the serum GPIHBP1 concentration in overweight/obese middle-aged women.
    Aruga M; Tokita Y; Nakajima K; Kamachi K; Tanaka A
    Clin Chim Acta; 2017 Dec; 475():109-115. PubMed ID: 29056530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease.
    Nozue T; Tada H; Murakami M; Michishita I
    J Clin Lipidol; 2023; 17(1):68-72. PubMed ID: 36402671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPIHBP1 autoantibody syndrome during interferon β1a treatment.
    Eguchi J; Miyashita K; Fukamachi I; Nakajima K; Murakami M; Kawahara Y; Yamashita T; Ohta Y; Abe K; Nakatsuka A; Mino M; Takase S; Okazaki H; Hegele RA; Ploug M; Hu X; Wada J; Young SG; Beigneux AP
    J Clin Lipidol; 2019; 13(1):62-69. PubMed ID: 30514621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.
    Shetty SK; Walzem RL; Davies BSJ
    J Lipid Res; 2020 Apr; 61(4):546-559. PubMed ID: 32029511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
    Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
    J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism.
    Liu C; Li L; Guo D; Lv Y; Zheng X; Mo Z; Xie W
    Clin Chim Acta; 2018 Dec; 487():33-40. PubMed ID: 30218660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene.
    Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S
    J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.